As a Medical Director at ICON plc, I oversee the design, execution, and reporting of clinical trials for hematological and oncological therapies, ensuring the highest standards of quality, ethics, and safety. With my experience as a physician, medical monitor, and medical advisor in the field of hematology-oncology, I have a deep understanding of the scientific, regulatory, and commercial aspects of drug development and medical affairs.My mission is to leverage my technical expertise, clinical acumen, and leadership skills to advance the development and delivery of innovative and effective treatments for patients with hematological and oncological diseases. I am passionate about collaborating with cross-functional teams, external partners, and key opinion leaders to provide strategic medical guidance, scientific insights, and clinical support throughout the product lifecycle. Some of my recent achievements include supporting the successful launch of novel cancer drugs, contributing to multiple publications and presentations, and leading the medical monitoring of a large-scale trials.